State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
Evid Based Complement Alternat Med. 2013;2013:819296. doi: 10.1155/2013/819296. Epub 2013 Aug 6.
Skimmin is one of the major pharmacologically active molecules present in Hydrangea paniculata, a medical herb used in the traditional Chinese medicine as an anti-inflammatory agent. In the current study, we attempted to investigate its renoprotective activity and underlying mechanisms in a rat model of membranous glomerulonephritis induced by cationic bovine serum albumin (c-BSA). Sprague-Dawley (SD) rats were divided into five groups, including normal control, model control, Mycophenolate Mofetil-treated group, and two skimming-treated groups (15 mg/kg and 30 mg/kg). Our research showed that treatment with skimmin significantly reduced the levels of blood urea nitrogen (BUN), urinary albumin excretion (UAE), and serum creatinine (Scr) as compared with model control after experimental induction of membranous glomerulonephritis (P < 0.01). Moreover, glomerular hypercellularity, tubulointerstitial injury, and glomerular deposition of IgG were less intense after skimmin treatment. By immunochemistry analysis, we demonstrated that skimmin could significantly inhibit interleukin-1 β (IL1 β ) and IL-6 expression (P < 0.05), reduce the loss of nephrin and podocin, and suppress the infiltration of renal interstitium by CD3-positive T cell and CD20-positive B cell. These results suggest that treatment with skimmin can significantly improve renal function and suppress the IgG deposition as well as the development of glomerular lesions in a rat model of membranous glomerulonephritis.
山奈酚是绣球花(一种传统中药中的药用植物,具有抗炎作用)中主要的具有药理活性的分子之一。在本研究中,我们试图在阳离子牛血清白蛋白(c-BSA)诱导的大鼠膜性肾小球肾炎模型中研究其肾保护活性及其潜在机制。SD 大鼠分为五组,包括正常对照组、模型对照组、吗替麦考酚酯治疗组和两种山奈酚治疗组(15mg/kg 和 30mg/kg)。研究结果表明,与模型对照组相比,在实验诱导膜性肾小球肾炎后,山奈酚治疗组的血尿素氮(BUN)、尿白蛋白排泄(UAE)和血清肌酐(Scr)水平显著降低(P<0.01)。此外,山奈酚治疗后肾小球细胞增生、肾小管间质损伤和肾小球 IgG 沉积减轻。通过免疫化学分析,我们证明山奈酚能显著抑制白细胞介素-1β(IL1β)和白细胞介素-6(IL-6)的表达(P<0.05),减少nephrin 和 podocin 的丢失,并抑制 CD3 阳性 T 细胞和 CD20 阳性 B 细胞浸润肾间质。这些结果表明,山奈酚治疗可显著改善肾功能,抑制 IgG 沉积,并抑制大鼠膜性肾小球肾炎模型肾小球病变的发展。